Hyperlipoproteinemia
| A | Type 1 | |
| B | Type 2a | |
| C | Type 2b | |
| D | Type 3 |
| A | Type 1 | |
| B | Type 2a | |
| C | Type 2b | |
| D | Type 3 |
Hyperlipidemia has been subclassified based on the lipid and lipoprotein profiles. Type 2a, which this patient has, can be seen in a hereditary form, known as familial hypercholesterolemia, and also in secondary, acquired forms related to nephritic syndrome and hyperthyroidism. The root problem appears to be a deficiency of LDL receptors, which leads to a specific elevation of cholesterol in the form of increased LDL. Heterozygotes for the hereditary form generally develop cardiovascular disease from 30 to 50 years of age. Homozygotes may have cardiovascular disease in childhood. Type 1 is characterized by isolated elevation of chylomicrons. Type 2b is characterized by elevations of both cholesterol and triglycerides in the form of LDL and VLDL. Type 3 is characterized by elevations of triglycerides and cholesterol in the form of chylomicron remnants and IDL. Type 5 is characterized by elevations of triglycerides and cholesterol in the form of VLDL and chylomicrons.
A young man presents to his physician’s office for a physical exam. He is concerned because his father died of a heart attack in his late 40’s. The physician finds that he has elevated serum cholesterol and LDL levels, but his VLDL and triglycerides are normal. Further investigation reveals an LDL receptor deficiency. This patient has which of the following types of hyperlipidemia?
| A |
Type I |
|
| B |
Type IIa |
|
| C |
Type IIb |
|
| D |
Type III |
A young man presents to his physician’s office for a physical exam. He is concerned because his father died of a heart attack in his late 40’s. The physician finds that he has elevated serum cholesterol and LDL levels, but his VLDL and triglycerides are normal. Further investigation reveals an LDL receptor deficiency. This patient has which of the following types of hyperlipidemia?
| A |
Type I |
|
| B |
Type IIa |
|
| C |
Type IIb |
|
| D |
Type III |
A patient with familial hypercholesterolemia undergoes a detailed serum lipid and lipoprotein analysis. Studies demonstrate elevated cholesterol in the form of increased LDL without elevation of other lipids. This patient’s hyperlipidemia is best classified as which of the following types?
| A |
Type 1 |
|
| B |
Type 2a |
|
| C |
Type 2b |
|
| D |
Type 3 |
A patient with familial hypercholesterolemia undergoes a detailed serum lipid and lipoprotein analysis. Studies demonstrate elevated cholesterol in the form of increased LDL without elevation of other lipids. This patient’s hyperlipidemia is best classified as which of the following types?
| A |
Type 1 |
|
| B |
Type 2a |
|
| C |
Type 2b |
|
| D |
Type 3 |
Hyperlipidemia has been subclassified based on the lipid and lipoprotein profiles.
Type 2a, which this patient has, can be seen in a hereditary form, known as familial hypercholesterolemia, and also in secondary, acquired forms related to nephritic syndrome and hyperthyroidism.
The root problem appears to be a deficiency of LDL receptors, which leads to a specific elevation of cholesterol in the form of increased LDL. Heterozygotes for the hereditary form generally develop cardiovascular disease from 30 to 50 years of age.
Homozygotes may have cardiovascular disease in childhood.
A 7 year old boy presented with generalized edema.
Urine examination revealed marked albuminuria.
Serum biochemical examinations showed hypoalbuminaemia with hyperlipidemia.
Kidney biopsy was undertaken.
On light microscopic examination, the kidney appeared normal.
Electron microscopic examination is most likely to reveal
| A |
Fusion of foot processes of the glomerular epithelial cells |
|
| B |
Rarefaction of glomerular basement membrane |
|
| C |
Deposition of electron dense material in the basement membrane |
|
| D |
Thin basement membrane |
A 7 year old boy presented with generalized edema.
Urine examination revealed marked albuminuria.
Serum biochemical examinations showed hypoalbuminaemia with hyperlipidemia.
Kidney biopsy was undertaken.
On light microscopic examination, the kidney appeared normal.
Electron microscopic examination is most likely to reveal
| A |
Fusion of foot processes of the glomerular epithelial cells |
|
| B |
Rarefaction of glomerular basement membrane |
|
| C |
Deposition of electron dense material in the basement membrane |
|
| D |
Thin basement membrane |
Answer is A (Fusion of foot processes of the glomerular epithelial cells):
The presence of generalized edema is a 7 year old boy with proteinuria suggests a diagnosis of Nephrotic syndrome.
This child is likely to have.
Minimal change disease as this is the most common cause of Nephrotic syndrome in children and is associated with normal findings on Light microscopy
Generalized edema May develop Pleural effusion, pulmonary edema, ascitis Patients with minimal change disease characteristically show fusion of foot processes of the glomerular epethelial cells on electron microscopy.
Minimal change Disease: Review
- Most common cause of Nephrotic syndrome in children (80% in children; 20% in adults)
- Peak Age of onset is between 6-8 years of Age (usually < 10 years)
- Type of onset : Insiduous
Clinical features
Peripheral Edema: Presenting Feature
Nephrotic syndrome is the typical presentation
Peripheral edema is the hallmark of Nephrotic syndrome occurring when serum albumin levels become less than 3g/dl
Initially dependent Edema > Generalized edema May develop Pleural effusion, pulmonary edema, ascitis
- Hematuria : 20-30%
- Hypertension : V. Rare
- Renal failure : Does not usually progress to renal failure
Laboratory (Features of Nephrotic syndrome)
- Proteinuria
- Hypoalbuminemia
- Hyperlipidemia/Hyper cholesterolemia (Increased hepatic prduction of lipids)
- Hypercoagulability
Renal pathology (Biopsy)
Investigation
- Light microscopy Q
- Electron microscopy Q
- Immunofluorescence Q
Observation
- No abnormality hence the term minimal change
- Fusion of foot processes
- Absence of immunoglobulin or complement
Prognosis
- Prognosis is Good
- Response to steroids is Excellent
- Does not progress to Renal Failure
Treatments
- Corticosteroids form the mainstay for treatment of MCD
Which can cause profound hyperlipidemia?
| A |
Hypoparathyroidism |
|
| B |
Hypothyroidism |
|
| C |
Hyperparathyroidism |
|
| D |
Hyperthyroidism |
Which can cause profound hyperlipidemia?
| A |
Hypoparathyroidism |
|
| B |
Hypothyroidism |
|
| C |
Hyperparathyroidism |
|
| D |
Hyperthyroidism |
Answer is B (Hypothroidism):
The two most common Endocrine causes of Secondary Dyslipidemia are Type-2 Diabetes Mellitus and Hypothyroidism.
Type-2 Diabetes Mellitus is the single most common endocrine cause of Secondary Dyslipidemia followed by Hypothyroidism.
Defect in type II hyperlipidemia
| A |
Apo-E |
|
| B |
Lipoprotein lipase |
|
| C |
LDL receptor |
|
| D |
None |
Defect in type II hyperlipidemia
| A |
Apo-E |
|
| B |
Lipoprotein lipase |
|
| C |
LDL receptor |
|
| D |
None |
Familial hypercholesterolemia (type Ha) is due to deficiency of functional LDL receptors as a result of different types of mutations.
Mechanism of action of fibrates in treatment of hyperlipidemia is ‑
| A |
Activator of lipoprotein lipase |
|
| B |
PPAR alpha agonist |
|
| C |
Decreased synthesis of VLDL |
|
| D |
Inhibitor of CETP |
Mechanism of action of fibrates in treatment of hyperlipidemia is ‑
| A |
Activator of lipoprotein lipase |
|
| B |
PPAR alpha agonist |
|
| C |
Decreased synthesis of VLDL |
|
| D |
Inhibitor of CETP |
Ans. is ‘a’ i.e., Activator of lipoprotein lipase

